Instagram Bio

Stage IV EGFR+ lung cancer survivor, diagnosed 2013, currently NED, co-founders of EGFR Resisters, alum of Princeton and Wharton/UPenn

Branded Content Partners

J&J Innovative Medicine

@jnjinnovativemedicine

View post

Contact

Engagement

Audience